TREATMENT SEQUENCING PATTERNS AND COSTS OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

被引：4
|
作者：
Potluri, R. [1 ]
Farr, A. M. [2 ]
Hirji, I [3 ]
Davis, C. [4 ]
Bhandari, H. [5 ]
Oukessou, A. [4 ]
机构：
[1] SmartAnalyst Inc, New York, NY USA
[2] Truven Hlth Analyt, Bethesda, MD USA
[3] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
[4] Bristol Myers Squibb Co, Princeton, NJ USA
[5] SmartAnalyst India Pvt Ltd, Gurgaon, India
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.1134
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN118
引用
收藏
页码：A450 / A450
页数：1
相关论文
共 50 条
  • [21] Tailoring Treatment for Multiple Myeloma Patients With Relapsed and Refractory Disease
    Richardson, Paul G.
    Laubach, Jacob
    Mitsiades, Constantine
    Schlossman, Robert L.
    Doss, Deborah
    Colson, Kathleen
    Mckenney, Mary L.
    Noonan, Kimberly
    Warren, Diane L.
    Ghobrial, Irene M.
    Munshi, Nikhil C.
    Anderson, Kenneth
    ONCOLOGY-NEW YORK, 2010, 24 (03): : 22 - 29
  • [22] Ruxolitinib and Methylprednisolone for Treatment of Patients with Relapsed/Refractory Multiple Myeloma
    Berenson, James R.
    Martinez, Daisy
    Safaie, Tahmineh
    Boccia, Ralph
    Yang, Honghao H.
    Moezi, Mehdi M.
    Lim, Stephen
    Schwartz, Gary Edward
    Eshaghian, Shahrooz
    Swift, Regina
    Eades, Benjamin
    Bujarski, Sean Elliott
    Regidor, Bernard Sean
    Kim, Clara
    Kim, Susanna
    Vescio, Robert
    BLOOD, 2022, 140 : 12610 - 12611
  • [23] Novel treatment approaches for patients with relapsed and refractory multiple myeloma
    Sinha R.
    Lonial S.
    Current Treatment Options in Oncology, 2006, 7 (3) : 246 - 257
  • [24] Selinexor for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM)
    Anum, Babar
    Hina, Zubair
    Mainoma, Bano
    Sana, Rafique
    Arzu, Shahid
    Maham, Babar
    Waleed, Madeeha S.
    Arslan, Inayat
    Danish, Safi
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 : S29 - S29
  • [25] Outcomes of Melflufen Treatment in Patients With Relapsed/Refractory Multiple Myeloma
    Hossain, Shahrier
    Mo, Clifton
    Patches, Sarah
    Leblebjian, Houry
    Goodrich, Kathryn
    Regan, Eileen
    O'Neill, Kathleen
    Noonan, Kim
    Richardson, Paul G.
    Laubach, Jacob
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [26] Ruxolitinib and methylprednisolone for treatment of patients with relapsed/refractory multiple myeloma
    Berenson, James R. R.
    Martinez, Daisy
    Safaie, Tahmineh
    Boccia, Ralph
    Yang, Honghao
    Moezi, Mehdi
    Lim, Stephen
    Schwartz, Gary
    Eshaghian, Shahrooz
    Swift, Regina
    Eades, Benjamin M. M.
    Bujarski, Sean
    Regidor, Bernard
    Kim, Clara
    Kim, Susanna
    Vescio, Robert
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (06) : 722 - 730
  • [27] PACE AS TREATMENT OF RESCUE IN PATIENTS WITH MULTIPLE RELAPSED OR REFRACTORY MYELOMA
    Isola, I.
    Granell, M.
    Marti Josep, M.
    Gironella, M.
    Garcia-Guinon, A.
    Lopez-Pardo, J.
    Muntanola, A.
    Abella, E.
    Motllo, C.
    Escoda, L.
    Sierra, J.
    Blade, J.
    Rosinol, L.
    Fernandez de larrea, C.
    HAEMATOLOGICA, 2015, 100 : 46 - 47
  • [28] Choosing treatment options for patients with relapsed/refractory multiple myeloma
    Castelli, Roberto
    Orofino, Nicola
    Losurdo, Agnese
    Gualtierotti, Roberta
    Cugno, Massimo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2014, 14 (02) : 199 - 215
  • [29] Current Real-World Treatment Patterns and Outcomes in Patients with Relapsed/Refractory Multiple Myeloma
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeannene
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne
    BLOOD, 2018, 132
  • [30] Estimating the Costs of Therapy in Patients with Relapsed and/or Refractory Multiple Myeloma: A Model Framework
    Roy, Anuja
    Kish, Jonathan K.
    Bloudek, Lisa
    Siegel, David S.
    Jagannath, Sundar
    Globe, Denise
    Kuriakose, Emil T.
    Migliaccio-Walle, Kristen
    AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (04): : 204 - 214
12345